MAPT and Guillain-Barre syndrome: Tau and neuron-specific enolase (NSE), another neuronal protein, have both been studied in GBS, with CSF levels of tau associated with worse short- and medium-term outcome [12, 13], and CSF levels of NSE [33] correlated with increased time to recovery [33].